<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01644487</url>
  </required_header>
  <id_info>
    <org_study_id>EV-10302</org_study_id>
    <nct_id>NCT01644487</nct_id>
  </id_info>
  <brief_title>Self-Expanding Nitinol Stent Versus Balloon Angioplasty Alone for the Below The Knee Arteries(SENS-BTK)</brief_title>
  <acronym>SENS-BTK</acronym>
  <official_title>Efficacy of Self-Expanding Nitinol Stent Versus Balloon Angioplasty Alone for the Below The Knee Arteries Following Successful Balloon Angioplasty Trial (Korean Vascular Intervention Multicenter Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Guro Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University Guro Hospital</source>
  <brief_summary>
    <textblock>
      The objectives of this study are to compare directly conventional balloon angioplasty alone
      versus. balloon angioplasty with routine stenting - that is, to determine whether angioplasty
      with self-expanding stent is superior to conventional balloon angioplasty - in the
      infrapopliteal arterial occlusive lesions of critical limb ischemia patients by collecting
      and analyzing the cases of each patient group in a prospective multicenter randomized
      clinical trial, and to clarify main factors affecting mid- and long-term clinical effects of
      angioplasty with self-expanding stent in the infrapopliteal arteries.

      Hypothesis: Balloon PTA followed by routine stenting with self-expanding nitinol stent in
      critical limb ischemia patients with infrapopliteal arterial occlusive lesions is superior to
      conventional PTA in the aspect of vascular restenosis rate.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Actual">September 6, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Provisional stenting with SMART(n=173), Provisional stenting with Complete SE(n=173)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Angiographic binary restenosis rate</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">232</enrollment>
  <condition>Critical Limb Ischemia</condition>
  <condition>Infrapopliteal Arterial Occlusive Disease</condition>
  <arm_group>
    <arm_group_label>Primary stenting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A group of patients who will undergo subsequent primary stenting following successful conventional balloon angioplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Balloon only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A group of patients who will undergo routine conventional balloon angioplasty alone without stenting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>self-expanding nitinol stent</intervention_name>
    <description>A group of patients who will undergo subsequent primary stenting following successful conventional balloon angioplasty</description>
    <arm_group_label>Primary stenting</arm_group_label>
    <other_name>Xpert stent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>balloon angioplasty</intervention_name>
    <description>A group of patients who will undergo routine conventional balloon angioplasty alone without stenting</description>
    <arm_group_label>Balloon only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic critical limb ischemia (Rutherford 4 - 6)

          -  Patients with signed informed consent

          -  Target lesion length &lt; 8 cm by angiographic estimation

          -  Stenosis of &gt;50% or occlusive atherosclerotic lesion of the ipsilateral infrapopliteal
             artery

          -  Reference vessel diameter should be 2.0-4.5 mm

        Exclusion Criteria:

          -  Patient has a known allergy to heparin, aspirin, or other anticoagulant/antiplatelet
             therapies or a bleeding diatheses or is unable, or unwilling, to tolerate such
             therapies

          -  Patient takes warfarin

          -  Patient has a history of previous life-threatening contrast media reaction

          -  Patient is currently enrolled in another investigational device or drug trial

          -  Patient is currently breast-feeding, is pregnant, or intends to become pregnant

          -  Patient is mentally ill or retarded

          -  Acute critical limb ischemia

          -  Major bleeding history within prior 2 months

          -  Severe hepatic dysfunction (&gt; 3 times normal reference values)

          -  Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding
             diathesis

          -  Life expectancy &lt;1 year due to comorbidity

          -  Reference segment diameter is not suitable for available stent design

          -  Previously implanted stent(s) or PTA at the same lesion site

          -  Inflow-limiting arterial lesions left untreated
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>152-703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2012</study_first_submitted>
  <study_first_submitted_qc>July 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2012</study_first_posted>
  <last_update_submitted>August 15, 2017</last_update_submitted>
  <last_update_submitted_qc>August 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Guro Hospital</investigator_affiliation>
    <investigator_full_name>Seung Woon Rha</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

